By: Kamal Kant Kohli, Medha Baranwal
China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors (SGLT2i) and pioglitazone
Medha Baranwal is an Editor at Medical Dialogues, where she has been since 2018. She covers a wide range of medical specialties including Cardiac Sciences, Dentistry, Diabetes, Diagnostics, and more, with a focus on medicine and healthcare. Medha has been featured in Money Haat and Medical Dialogues, showcasing her expertise in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Medha's focus on citing data and coverage of medical research, health conditions, treatment options, risk factors, and disease prevention suggests she would be interested in pitches featuring new scientific studies or clinical trials with significant findings.
Pitches providing access to experts who can analyze the methodology and implications of newly released data or provide insights into the practical applications of medical research are likely to resonate well with her.
Given Medha’s geographic focus on India and her coverage that is centered around healthcare and pharmaceuticals, consider tailoring pitches by highlighting any relevance to the Indian market or including perspectives from professionals based in India.
This information evolves through artificial intelligence and human feedback. Improve this profile .